Results 201 to 210 of about 60,195 (236)
Some of the next articles are maybe not open access.
Urothelial Carcinoma of the Prostate
Urology, 2007This study was conducted to explore the diagnosis and management of urothelial carcinoma of the prostate in superficial disease and carcinoma in situ, stromal invasion, primary urothelial carcinoma, and urethral recurrence after radical surgery. A consensus conference convened by the World Health Organization (WHO) and the Société Internationale d ...
Juan, Palou +9 more
openaire +2 more sources
Avelumab Maintenance for Urothelial Carcinoma
New England Journal of Medicine, 2020To the Editor: Powles et al. (Sept. 24 issue)(1) report the practice-changing results of the JAVELIN Bladder 100 trial, which assessed the advantage of maintenance avelumab therapy plus best supportive care over best supportive care alone with respect to overall survival among patients with advanced urothelial carcinoma who had had a response to first ...
Mollica V., Rizzo A., Massari F.
openaire +4 more sources
Glycosaminoglycans in urothelial carcinomas
Urological Research, 1983The glycosaminoglycan (GAG) content in human urothelial carcinomas was biochemically determined and compared to that of normal urothelium and bladder wall of the calf. The total GAG content was elevated in urothelial carcinomas, and the distribution pattern differed from that of normal urothelium and bladder wall.
H, Rübben +3 more
openaire +2 more sources
The origins of urothelial carcinoma
Expert Review of Anticancer Therapy, 2010It is now widely believed that there are two major pathways for urothelial carcinogenesis. One pathway usually involves mutation of FGF receptor 3 and gives rise to low-grade papillary tumors that frequently recur but seldom invade. By contrast, high-grade urothelial malignancies, including high-grade papillary urothelial carcinoma and urothelial ...
Liang, Cheng +7 more
openaire +2 more sources
ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma
Human Pathology, 2016ARID1A mutation leads to loss of the products of this tumor-suppressor gene. Studies demonstrated ARID1A mutation in 20% of stage IV urothelial carcinomas (UCs) with worse prognosis. The expression of ARID1A in aggressive variants of UC is not studied properly.
Jianhong, Li +4 more
openaire +2 more sources
Epigenetics of Urothelial Carcinoma
2014Urothelial carcinoma is the most frequent type of bladder cancer. Improvements in diagnostics and therapy of this common tumor are urgently required and need to be based on a better understanding of its biology. Epigenetic aberrations are crucial to urothelial carcinoma development and progression.
Wolfgang A, Schulz +3 more
openaire +2 more sources
The use of MRI in urothelial carcinoma
Current Opinion in Urology, 2022Purpose of review To conduct a nonsystematic review of the existing literature to investigate the role of Magnetic Resonance Imaging (MRI) in urothelial carcinomas (UCs). Recent findings Imaging is becoming progressively more crucial in local and distant staging of UCs, especially ...
Messina, Emanuele +5 more
openaire +3 more sources
Urothelial carcinoma in a mule
Journal of Equine Veterinary ScienceEquine bladder neoplasms are rare. This report aimed to describe the clinical signs and treatment of urothelial carcinoma (UC) in a mule. Cystoscopy of a 20-year-old female mule with a one-week history of hematuria and anemia revealed vascular congestion in the mucosa and an intraluminal, pedunculated mass in the dorsal bladder region ...
A C, Valim +6 more
openaire +2 more sources
Urothelial Carcinoma of the Kidney and Ureter
British Journal of Urology, 1980Summary— Two hundred and three patients with upper tract urothelial tumours were reviewed. Eighty had pelvicaliceal tumours, 90 ureteric tumours, and 33 multifocal tumours of both pelvis and ureter. Two hundred patients had transitional cell carcinomas and 3 had squamous cell carcinomas.
C M, Booth, K M, Cameron, R C, Pugh
openaire +2 more sources